Autologous Hematological Stem Cell Transplantation for Systemic Sclerosis in Israel.
CONCLUSIONS: HSCT is an important step in the treatment of progressive SSc in Israel. Careful patient selection reduces treatment related morbidity and mortality.
PMID: 32043328 [PubMed - in process]
Source: The Israel Medical Association Journal - Category: General Medicine Tags: Isr Med Assoc J Source Type: research
More News: Carbon Monoxide Poisoning | Cardiology | Congestive Heart Failure | General Medicine | Heart | Heart Failure | Heart Transplant | Hematology | Israel Health | Laboratory Medicine | Lung Transplant | Middle East Health | Pediatrics | Scleroderma | Skin | Stem Cell Therapy | Stem Cells | Transplants